STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma.

Scuto, Anna; Kujawski, Maciej; Kowolik, Claudia; Krymskaya, Ludmila; Wang, Lin; Weiss, Lawrence M; Digiusto, David; Yu, Hua; Forman, Stephen; Jove, Richard

Scuto, Anna; Kujawski, Maciej; Kowolik, Claudia; Krymskaya, Ludmila; Wang, Lin; Weiss, Lawrence M; Digiusto, David; Yu, Hua; Forman, Stephen; Jove, Richard.

Affiliation

Scuto A; Department of Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. ascuto@coh.org

Cancer Res ; 71(9): 3182-8, 2011 May 01.

Article in En | MEDLINE | ID: mdl-21521803

Subject(s)

Lymphoma, Large B-Cell, Diffuse/therapy; STAT3 Transcription Factor/antagonists & inhibitors; Animals; Cell Line, Tumor; Down-Regulation; Humans; Lymphoma, Large B-Cell, Diffuse/drug therapy; Lymphoma, Large B-Cell, Diffuse/genetics; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Molecular Targeted Therapy/methods; RNA, Small Interfering/administration & dosage; RNA, Small Interfering/genetics; STAT3 Transcription Factor/genetics; STAT3 Transcription Factor/metabolism; Xenograft Model Antitumor Assays

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / STAT3 Transcription Factor Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2011 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google